Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes
Figure 9
Changes in lipids (mg/dL) in 156 obese hypogonadal men with type 2 diabetes treated with testosterone undecanoate injections for up to 6 years. HDL cholesterol (a). Total cholesterol, LDL cholesterol, and triglycerides (b).